NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
ID: 348406Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for the NEI Collaborative Clinical Vision Research Project through a Coordinating Center grant (UG1 Clinical Trial Required). This grant aims to support large-scale clinical trials focused on evaluating interventions for vision disorders, requiring applicants to demonstrate the project's significance, innovation, and the capabilities of the Principal Investigators. The Coordinating Center will be responsible for providing scientific and technical leadership, managing trial data and safety oversight, and collaborating with various research centers. There is no explicit budget cap, and the optimal project duration is up to five years. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 25, 2026.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Eye Institute (NEI) is offering funding opportunities for Collaborative Clinical Vision Research Projects through a Coordinating Center grant (UG1 Clinical Trial Required). The grant aims to support large-scale clinical trials focused on evaluating interventions for vision disorders. Key responsibilities of the Coordinating Center include providing scientific and technical leadership, managing trial data and safety oversight, and collaborating with various research centers. Applications for this competitive grant must adhere to strict guidelines and demonstrate the project's significance, innovation, and the capabilities of the Principal Investigators. Various types of institutions, including higher education and nonprofit organizations, are encouraged to apply. The optimal project duration is up to five years, and while there is no explicit budget cap, applications must accurately reflect project needs. This funding initiative emphasizes the NEI's commitment to advancing vision research and improving public health outcomes related to vision disorders.
    Similar Opportunities
    NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NEI Collaborative Clinical Vision Research Project, specifically for Resource Center Grants (UG1 Clinical Trial Required). This initiative aims to support large-scale clinical trials focused on screening, diagnosing, preventing, or treating vision disorders, with a particular emphasis on evaluating complex interventions and providing essential services for multi-center trials. The NEI seeks to advance vision health through rigorous research, and applications are encouraged from a diverse range of eligible applicants, including various educational institutions and organizations. Interested parties must submit their applications by May 25, 2026, and can find additional information and guidelines at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Eye Institute (NEI), has announced a Notice of Funding Opportunity (NOFO) for the NEI Collaborative Clinical Vision Research: Chair's Grant (UG1), aimed at supporting large-scale clinical trials focused on vision disorders. This funding opportunity is intended for projects that evaluate interventions for screening, diagnosing, preventing, or treating vision disorders, specifically requiring a clinical trial with a clear scientific rationale and detailed study design. The NEI emphasizes the importance of these trials in advancing vision science and public health, with awards structured as cooperative agreements to ensure substantial NIH involvement in the research process. Interested applicants must submit their proposals by May 25, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) to support the planning and development of clinical vision research studies. This grant program aims to advance knowledge in eye and vision conditions by funding the development of study protocols and manuals, as well as fostering collaborative research efforts, while explicitly prohibiting the generation of data from clinical trials or preclinical studies. Eligible organizations, including educational institutions and nonprofits, can apply for grants of up to $150,000 per year for a maximum of two years, with applications due by January 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-358.html.
    NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed), aimed at facilitating the rapid translation of innovative laboratory research into therapeutics for visual system diseases. This grant program supports the development of biological, pharmaceutical, medical device, and combination therapies, utilizing a bi-phasic, milestone-driven approach where the R61 phase focuses on preliminary research and the R33 phase advances candidates towards clinical trials. Interested applicants, including independent school districts and community-based organizations, can expect up to five awards with no cost-sharing requirement, and should prepare to submit applications by February 16, 2026, with an estimated award date of December 1, 2026. For further inquiries, contact Tony Gover, Ph.D., at tony.gover@nih.gov or call 301-529-7320.
    NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed). This grant aims to support meritorious research projects that utilize existing databases for secondary data analyses related to vision health, with a focus on enhancing statistical methodologies for analyzing vision data. The initiative is crucial for addressing major causes of blindness and improving the understanding of visual system development and function. Eligible applicants include a wide range of institutions, and the total project budget can reach up to $275,000 over two years. Interested parties should submit their applications by October 16, 2027, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-357.html.
    NEI New Innovator Award (DP2 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NEI New Innovator Award, a federal grant aimed at supporting early-stage investigators and postdoctoral candidates in vision research. This opportunity encourages innovative and original research proposals that have the potential to significantly impact the field of vision science, particularly those that explore novel methodologies or interdisciplinary approaches. The program anticipates awarding four grants, with no cost-sharing requirements, and applications are due by May 25, 2026, with an estimated award date of August 2, 2026. For further inquiries, interested applicants can contact Ed Clayton, Ph.D., at 240-987-8255 or via email at Ed.clayton@nih.gov.
    NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44), aimed at supporting small business concerns (SBCs) conducting early-stage clinical trials related to vision disorders. Applicants are required to propose studies that evaluate interventions for screening, diagnosing, preventing, or treating eye diseases, with a focus on trials that typically fall under Phase I or II and involve greater than minimal risk, necessitating appropriate oversight and safety monitoring. This initiative underscores the government's commitment to advancing clinical research and innovation in vision health, with applications due by January 7, 2027. Interested applicants can find more information and guidance by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-066.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at advancing vision health equity through multi-level interventions and community-engaged research. This initiative, led by the National Eye Institute (NEI) in collaboration with other NIH Institutes and Centers, seeks to solicit applications for research projects that address disparities in vision health. The funding opportunity is significant, with an estimated total program funding of $7 million and an award ceiling of $1 million, expecting to support approximately six awards. Interested applicants should note that the NOFO is anticipated to be published in Winter 2025, with applications due in early Spring 2025, and the estimated award date is set for December 1, 2025.
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) aimed at advancing the diagnosis, prevention, treatment, and amelioration of human sensory and communication disorders. This funding opportunity supports integrated, multidisciplinary research programs that include 3-4 synergistic research projects and an administrative core, with the possibility of 1-2 optional scientific cores, all centered around a unifying clinical theme. The maximum project period is five years, with budgets capped at $1,500,000 in direct costs per year for new applications. Eligible applicants include various organizations, excluding foreign entities, and are encouraged to consult with NIDCD staff prior to submission to ensure responsiveness. The application deadline is June 2, 2028, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional), aimed at fostering innovative institutional research career development programs for clinician-vision scientists. This funding opportunity encourages institutions to prepare these professionals for independent research careers, with a focus on minimal risk clinical trials and the recruitment of scholars from underrepresented racial and ethnic groups. The program is crucial for enhancing the community of clinician investigators in vision research, with awards contingent upon NIH appropriations and a maximum project period of five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with the application deadline set for June 9, 2026.